Health Care & Life Sciences » Pharmaceuticals | Mangalam Drugs & Organics Ltd.

Mangalam Drugs & Organics Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3
9
7
9
21
Total Accounts Receivable
297
465
360
450
623
Inventories
365
573
473
372
679
Other Current Assets
32
113
156
142
-
Total Current Assets
697
1,160
997
973
1,323
Net Property, Plant & Equipment
534
529
591
926
1,012
Total Investments and Advances
6
9
-
-
-
Long-Term Note Receivable
-
-
-
-
17
Intangible Assets
-
-
-
-
8
Other Assets
18
-
10
12
-
Total Assets
1,254
1,699
1,598
1,910
2,360
ST Debt & Current Portion LT Debt
370
386
429
455
508
Accounts Payable
209
548
207
208
376
Income Tax Payable
-
-
1
2
-
Other Current Liabilities
36
61
92
76
193
Total Current Liabilities
614
995
729
740
1,077
Long-Term Debt
402
394
169
207
111
Deferred Taxes
6
17
84
102
120
Other Liabilities
-
-
-
-
-
Total Liabilities
1,022
1,405
982
1,049
1,308
Common Equity (Total)
232
294
615
862
1,052
Total Shareholders' Equity
232
294
615
862
1,052
Total Equity
232
294
615
862
1,052
Liabilities & Shareholders' Equity
1,254
1,699
1,598
1,910
2,360

About Mangalam Drugs & Organics

View Profile
Address
Rupam Building
Mumbai Maharashtra 400001
India
Employees -
Website http://www.mangalamdrugs.com
Updated 09/14/2018
Mangalam Drugs & Organics Ltd. engages in the manufacture of drugs, medicines and allied products. Its products include Allopurinol, Amodiaquin, Dichloroquinoline, Menthol, Lumefantrine, Amodiaquine Hydrochloride and Artemether. The company was founded in 1977 and is headquartered in Mumbai, India.